They say the first casualty of war is the truth. Based upon recent events in the U.S. presidential elections, it looks like the truth is a casualty in politics as well. Whether out of desperation, ignorance, or political convenience, current and former contenders for the Republican presidential nomination have been questioning the long-term economic value … Continue reading ““Vulture” Capital? Far From It”
Category: New York
Producteev Launches Windows App to One-Up Competition in Task Management
New York’s Producteev released on Tuesday the first Windows desktop version of its task management software in an effort to become more ubiquitous than its rivals. Producteev’s software lets users who work collaboratively organize, update, and see who is responsible for getting specific jobs done. The platform can be accessed via mobile apps, the Web, … Continue reading “Producteev Launches Windows App to One-Up Competition in Task Management”
Report: Gilt Layoff Rumors Confirmed, Two Top Execs Depart
Even the hottest companies suffer growing pains, as evidenced by the recent layoffs at Gilt Groupe, the flash-sales site that raised a remarkable $138 million in a Series E financing earlier this year and later bought troubled daily-deals site BuyWithMe. After weeks of rumors, Gilt’s CEO Kevin Ryan told AllThingsD that Gilt has cut 10 percent of … Continue reading “Report: Gilt Layoff Rumors Confirmed, Two Top Execs Depart”
Q&A: What DFJ Gotham Sees in E-Commerce Plays Like Moms’ Site Totsy
When New York-based e-commerce site Totsy raised a $5 million Series A in late 2010, the startup gained the expertise of two of New York’s best-known venture capital groups: Rho Ventures and DFJ Gotham Ventures, which led the round. Since then, the site—which holds limited time “flash sales” of merchandise for parents and children—has grown … Continue reading “Q&A: What DFJ Gotham Sees in E-Commerce Plays Like Moms’ Site Totsy”
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting
Mark Twain used to toss around a saying about three kinds of lies. There are lies, damned lies, and statistics. This week in biotech, we saw some statistics that could lead some people to get a false impression that everything is just peachy in biotechland. If you measure the state of life science innovation by … Continue reading “Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting”
Finnish Startup Playmysong Raises Seed Round, Opens NYC Office
Finland’s Playmysong said in a press release it raised a seed round, $350,000 according to a spokesman, led by startup accelerator Lifeline Ventures and opened a New York office this month. The company plans to also set up shop in San Francisco in February. Playmysong’s Apple iOS and Web app lets users request songs to … Continue reading “Finnish Startup Playmysong Raises Seed Round, Opens NYC Office”
Tweet Chat Today with John Seely Brown on Education and the Future
There is hardly a more important topic to society than the future education. So I’m really looking forward to hosting a Tweetchat later today on education and the future. My guest will be John Seely Brown (@jseelybrown), the technology visionary who previously served as chief scientist of Xerox and also director of Xerox PARC, the … Continue reading “Tweet Chat Today with John Seely Brown on Education and the Future”
The 10 Social News Apps You Need to Try
Once upon a time, there was a magical innovation called RSS, for Rich Site Summary or Really Simple Syndication. It freed news articles, podcasts, and other content from their original homes on the Web and allowed news junkies to follow their favorite publications and blogs through story streams called news feeds, which could be bundled … Continue reading “The 10 Social News Apps You Need to Try”
Clarus Ventures Adjusts to Unpredictable Biotech World
[[Correction: 11:20 am ET]] It’s never been easy to make a buck in biotech venture capital, but there used to be more predictability and logic to it, according to Clarus Ventures’ Nick Galakatos. You’d invest a few million, or tens of millions, and push a new drug or device toward some scientific validation in a … Continue reading “Clarus Ventures Adjusts to Unpredictable Biotech World”
AppAddictive Garners $1,200,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=130f720e-29fb-4bda-9d72-f5e6d70a7f4c&Preview=1 Date 1/20/2012 Company Name AppAddictive Mailing Address 122 W. 26th St 5th Floor New York, NY 10001 Company Description AppAddictive’s clients have seen as much as 69% savings in customer acquisition costs. AppAddictive’s apps have over 50 million Facebook users. AppAddictive powers over 20 million Facebook fans. Website http://www.appaddictive.com Transaction Type … Continue reading “AppAddictive Garners $1,200,000 Seed Round”
Xconomist of the Week Chris Rizik: Who Says A VC Has No Soul?
Chris Rizik is one of Michigan’s most important and successful venture capitalists. He’s the CEO and fund manager of Renaissance Venture Capital, a fund of funds that is perhaps best known for its early backing of the medical device company HandyLab, a University of Michigan spinout that was later purchased by New Jersey’s Becton Dickinson … Continue reading “Xconomist of the Week Chris Rizik: Who Says A VC Has No Soul?”
Georgia Startups Have New York on Their Minds at Flashpoint Demo Day
A flotilla of fifteen startups from Atlanta presented their ideas in New York on Wednesday for a demo day at the offices of Union Square Ventures. Merrick Furst, director of the Flashpoint accelerator at the Georgia Institute of Technology, said the program helps entrepreneurs develop their concepts beyond their startup phase. “They are trying to … Continue reading “Georgia Startups Have New York on Their Minds at Flashpoint Demo Day”
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs
After the stock market closed last night, New York-based Bristol-Myers Squibb (NYSE: [[ticker:BMY]]) announced that a cocktail containing two of its experimental drugs to treat hepatitis C obliterated the virus in some patients in a Phase 2 study. The results were so compelling the company used the “C” word in a press release, declaring, “This … Continue reading “A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs”
WeFi Lands $10,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=75eccbe9-1fda-44a8-adc7-3d03170c4d38&Preview=1 Date 1/19/2012 Company Name WeFi Mailing Address 826 Broadway New York, NY 10003 Company Description WeFi is software loaded onto your laptop or mobile device. It enhances your existing WiFi management software with a more powerful connection tool. The WeFi software automatically detects and qualifies all WiFi access points within range … Continue reading “WeFi Lands $10,000,000 New Financing Round”
Namely Receives $1,000,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=32bc0cab-d506-4658-8448-a9acc8527ee3&Preview=1 Date 1/19/2012 Company Name Namely Mailing Address 33 Nassau Avenue 2nd Floor Brooklyn, NY 11222 Company Description Namely is the first talent management platform built for the professional services industry—specifically advertising. Namely enables agencies to manage their teams, retain key employees and grow revenues. Website http://www.namely.com Transaction Type Venture Equity Transaction … Continue reading “Namely Receives $1,000,000 Seed Funding”
SOPA-PIPA Protests Blossom Across the Country
It’s not just Wikipedia that’s throwing its weight today behind the movement to stop the controversial anti-piracy bills moving through the U.S. Congress. While the English version of the world’s most-visited encyclopedia site has gone dark for the day to call attention to the perceived dangers of the Stop Online Piracy Act and the Protect … Continue reading “SOPA-PIPA Protests Blossom Across the Country”
Five Questions on Tech in NYC for North Bridge VC Dayna Grayson
Dayna Grayson, principal at North Bridge Venture Partners in Waltham, MA, has been spending a lot of time in New York City of late. North Bridge wants to participate in the Big Apple’s technology renaissance, so Grayson has been spending one to two days a week scouting for investment opportunities. North Bridge’s New York investments … Continue reading “Five Questions on Tech in NYC for North Bridge VC Dayna Grayson”
Women in Science 2012 Forum
“Inspiring women scientists” is the theme of this day-long conference sponsored by the City University of New York and Feminist Press. Speakers include Jill Tarter, director of the Center for SETI Research at the SETI Institute, Mary Kicza, assistant administrator for satellite and information sciences and the National Oceanic and Atmospheric Administration, and Doris Cully, … Continue reading “Women in Science 2012 Forum”
J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’
Johnson & Johnson’s West Coast research leader, Diego Miralles, has met with a lot of biotech entrepreneurs who are curious about what J&J is doing to foster more startups at its facility in San Diego. At some point, a skeptical question usually comes up. “What’s the catch?” Miralles says he’s sometimes asked. He insists there … Continue reading “J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’”
What Should Students Study? Read the Xconomist Report on Education
Yesterday Bob told you about a special report we put together by canvassing the Xconomists—some of the world’s leading innovators, entrepreneurs, and investors—for their thoughts on what students should study to be prepared for the future. Well, the report is now live, here, with 22 thought-provoking responses. Computing, the scientific method, culture, Chinese, and how to start … Continue reading “What Should Students Study? Read the Xconomist Report on Education”
The World is Your Campus: Study with Rigor, Be Entrepreneurial
Two trends are driving the current job market: globalization, where everybody is becoming part of the economy, and innovation, which increases productivity and allows fewer people to do the same jobs. These two trends will not slow down during the next few decades. How should students train in college to build careers under these conditions? … Continue reading “The World is Your Campus: Study with Rigor, Be Entrepreneurial”
Merging Hand and Mind
My pat answer is mathematics (the universal language), biology (in order to master non-linear, dynamic thinking especially related to complex systems and ecosystemic issues) and Chinese (since in 10 years Chinese will be even more important than it is today in both the commercial and scientific domains). But let’s peek around the corner. Both design … Continue reading “Merging Hand and Mind”
Critical Thinking and the Scientific Process First—Humanities Later
If luck favors the prepared mind, as Louis Pasteur is credited with saying, we’re in danger of becoming a very unlucky nation. Little of the material taught in schools today is relevant to the future. Consider all the science and economics that has been updated, the shifting theories of psychology, the programming languages, political theories, … Continue reading “Critical Thinking and the Scientific Process First—Humanities Later”
Turning Data into Meaning
More than anything, they should be studying math, including statistics and probability, and programming. No matter what the subject, we will have huge amounts of data about it, and will need these tools to get meaning from the data. The areas I’m thinking of include medicine, genetics, nutrition, and neuroscience; human behavior; energy management and … Continue reading “Turning Data into Meaning”
Not All Tech Companies Are Alike
From cloudy Seattle to the vast suburbs of Silicon Valley, we covered a lot of ground on MIT Sloan’s recent technology trek, which concluded with a leg in Boston. The first stop was Seattle where it was predictably raining. Visiting Amazon, Microsoft, and Adobe, we came away with an appreciation for how much tech activity … Continue reading “Not All Tech Companies Are Alike”
Learning Across Disciplines and Cultures
The world is only going to become more technological and more global in the next decade. Students should be getting a solid enough grounding in mathematics, probabilistic thinking, physics, chemistry, biology, and engineering that they understand these ways of thinking and the values of these fields. They also need a liberal arts grounding and, particularly, … Continue reading “Learning Across Disciplines and Cultures”
CS + X, for all X
The impact of information-based technologies will continue to grow—probably at an accelerating rate. In nearly every segment of society, we see both quality and productivity improvements because of increased use of automation and digital communication. The impact is obviously huge in some sectors such as finance and publishing. And it will only grow in the … Continue reading “CS + X, for all X”
From AI to Bioengineering
First of all, students should be studying what they are passionate about. Clearly, computer science will continue to spread into all aspects of human life. Within computer science, I believe machine learning and AI are perhaps the biggest study opportunity today. Biology and medicine are also undergoing vast changes. Personalized medicine will become a big … Continue reading “From AI to Bioengineering”
Study the Boomers!
The Who once sang, “I hope I die before I get old.” Despite their best efforts to exit the planet early, most of them didn’t. They and their fellow Baby Boomers represent the greatest technology and business opportunity of the 21st Century. It is typical for each of us to be drawn to areas for … Continue reading “Study the Boomers!”
The Convergence of Biology, Medicine, and Engineering
I think learning the fundamentals of a discipline is the most important thing that students can do to prepare themselves for jobs both today and tomorrow. That discipline may be biology, bioengineering, chemistry, chemical engineering or others. I also think doing research is great preparatory experience. Furthermore, I believe the opportunities offered by the convergence … Continue reading “The Convergence of Biology, Medicine, and Engineering”
Computing and-Chinese
My initial response to this question was, “Chinese!” I was only half joking. English is the most popular second language in the world and in our increasingly connected world, the people who have an understanding of other languages—particularly Chinese—will be better equipped. As far as computers go, I studied computer languages in school and even … Continue reading “Computing and-Chinese”
Writing, Literature, and Computer Science
Whether you major in it or not, a fairly non-trivial amount of computer science would be helpful. The other thing is communication. One of the main things we look for when we are hiring people is their ability to write. It’s something that the average person is pretty poor at, but so much of every … Continue reading “Writing, Literature, and Computer Science”
Anything They’re Passionate About
Anything that interests them and they are passionate about today. What they will need to know in 10 years does not exist now, given the exponential growth of knowledge.
Data Analysis and Sensing
How to sense and make sense of subtler factors that govern our behaviors, the choices we make as individuals and as part of groups. The point here is that there are some obvious physically measurable; things like body weight, miles driven, CO2 let out, around which we can develop diagnostics and policies. But these measurables … Continue reading “Data Analysis and Sensing”
Learn to Learn, and Embrace Serendipity
Here is my advice to students considering pursuing science: —Learn how to learn (science is progressing so rapidly that whatever field you are focused on today will inevitably be different 10 years from now) —Learn how to develop focused attention (i.e. avoid modern day distractions like Twitter) —Master multiple science disciplines—If you can bridge disciplines … Continue reading “Learn to Learn, and Embrace Serendipity”
Learn By Starting Things
Students should be studying how to start things-how to create and grow new products, initiatives, ventures, and enterprises-a skill set that never goes out of style and that is fundamental to our nation’s future well-being and prosperity. And the best way to learn how to start things is to actually try to start things-whether it … Continue reading “Learn By Starting Things”
Marrying the Humanities and the Sciences
Liberal science and technology. We need a new major that prepares the future workforce for constant change by teaching broad-based knowledge in many disciplines. This major would consist of, among other disciplines, the basics of engineering, biology, chemistry, physics, law, business, humanities and communications. This curriculum should be group-based, where students teach each other, which … Continue reading “Marrying the Humanities and the Sciences”
Engaging “Productive Stupidity”
I recently came across an article in Cell Science that intrigued me and gets to the core of this question. The title—“The Importance of Stupidity in Scientific Research”—was reason alone to pique my curiosity. What I didn’t expect was to find a powerful insight into student learning in today’s highly uncertain world. Martin A. Schwartz, … Continue reading “Engaging “Productive Stupidity””
Be Students of Life
Themselves. Technology, markets, financial vehicles, business methodology, government regulations, entertainment, media, and so on, all aspects of our professions and our entire lives will change at a continuously increasing rate in perpetuity. Which technology, market, industry should I commit to? I don’t believe this is the most relevant question for a student. More relevant questions … Continue reading “Be Students of Life”
Biology 101
Biology 101 and beyond. I would take as much biology as possible, it’s exploding and changing faster than anyone could have expected. Especially our understanding of the “central dogma” itself, where RNA is playing a more critical role than ever thought before. WOW!
Culture, Science, and Problem Solving
As a father of two girls, I have actually been thinking about this quite a bit. In general, I want my kids to be prepared for a world that is going to be very, very different from the world I grew up in, largely due to the travel, communications, and the Internet. I would recommend … Continue reading “Culture, Science, and Problem Solving”
Meta-Processing
Both what we are teaching and learning, and how we are teaching and learning, are changing, very, very rapidly. The notion that there is a gold standard—a favored text or tome, a single subject-matter expert, or a single corporation with the single best practice, in any discipline—is really outdated. The ‘new normal’ is generation of … Continue reading “Meta-Processing”
Global Healthcare
College undergraduates today are faced with many choices of where to concentrate their studies. It is important to look down the road to determine where the major unmet needs of society will be. The healthcare industry offers many opportunities and challenges over the coming decades. As I look to the future of healthcare, there are … Continue reading “Global Healthcare”
Notes From the Detroit Auto Show: Connectivity is King
Though the North American International Auto Show just opened to the public Saturday, I was able to preview it last week with other reporters from around the world. Unlike the past few years, which were dominated by austerity and green tech, the feeling I got this year is that the car companies are seeking to … Continue reading “Notes From the Detroit Auto Show: Connectivity is King”
ShopKeep.com Raises $2.2M in Series A Round, Plans New Hires
New York’s ShopKeep.com says it raised $2.2 million in a Series A funding round led by Tribeca Venture Partners and TTV Capital. Contour Venture Partners also participated in the round. ShopKeep developed a point-of-sale platform that retailers can use on the Apple iPad as well as with Mac-powered registers. The company also provides Web-based software, which … Continue reading “ShopKeep.com Raises $2.2M in Series A Round, Plans New Hires”
Xconomists Peer into the Future, Suggest How Students Should Prepare
[Updated, Jan. 18, 2012—The Xconomist Report on the Future of Education is live—click here.] As the presidential race picks up steam, you know that we will be hearing a lot—a lot more, that is—about the need to create jobs. But where will those jobs come from, and what fields are really likely to spur growth … Continue reading “Xconomists Peer into the Future, Suggest How Students Should Prepare”
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership
Medivation’s long shot for Alzheimer’s came up short today. The San Francisco-based company (NASDAQ: [[ticker:MDVN]]) said today its Alzheimer’s drug candidate dimebon failed in a pivotal clinical trial. Medivation and its collaborator, Pfizer, said they plan to quit developing the drug. The bad news came from a trial known as Concert, which enrolled more than … Continue reading “Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership”
1stdibs CEO Seeks Queries For VCs Wilson, Dagres at Xconomy Forum
Day in and day out, venture capitalists ask questions of entrepreneurs—some might say grill them. But on February 1, at Xconomy’s New York Venture Emergence forum, former DoubleClick CEO David Rosenblatt, who’s now CEO of luxury online marketplace 1stdibs and chairman/co-founder of Group Commerce, will help us turn the tables. Rosenblatt will be the moderator … Continue reading “1stdibs CEO Seeks Queries For VCs Wilson, Dagres at Xconomy Forum”
Reinventing the Board Part III: The Agenda
CEOs, investors, and board members frequently complain about ineffective board meetings. Steve Blank, Jeff Bussgang, Brad Feld, and Fred Wilson each have suggested board meetings could be improved by changing the format, process, or content. Having good meetings starts by having the right people in the room (as discussed in the first installment of this … Continue reading “Reinventing the Board Part III: The Agenda”
Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks
Chris Viehbacher has seen plenty of ideas come and go from people trying to shake up the pharma R&D model. No matter how much people have tried to fix things, it still takes a notorious amount of time, money, and risk to create new drugs. Now, as the CEO of Paris-based Sanofi (NYSE: [[ticker:SNY]]), Viehbacher … Continue reading “Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks”